miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 15, 2026

BlackRock Q4 Earnings Call Highlights

View original at finance.yahoo.com
BlackRock Q4 Earnings Call Highlights BlackRock logo Key Points Record net inflows: BlackRock reported roughly $698 billion of net new assets in 2025, led by iShares with about $527 billion of flows and double-digit organic base-fee growth across core equity, fixed income, active and digital ETPs…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The as-adjusted tax rate was approximately 20% in Q4 2025 due to discrete items, and 25% is a reasonable projected tax run rate for 2026.

    80% confidence
  • Clients awarded BlackRock nearly $700 billion in net new assets in 2025, alongside 9% organic base fee growth and 16% technology ACV expansion.

    80% confidence
  • Private markets to insurance, private markets to wealth, digital assets, and active ETFs can each be $500 million revenue generators in the next five years.

    80% confidence
  • 2025 was one of the strongest years in BlackRock's history, with record net inflows, accelerating organic base fee growth, and continued expansion in technology services.

    80% confidence
  • BlackRock is engaged in roughly 20 late-stage conversations to help insurers build more diversified portfolios and hopes to see deployments pull through the second half of 2026.

    80% confidence
  • BlackRock continues to target a 45% or greater adjusted operating margin profile, with upward momentum in margins on recurring fee-related earnings.

    80% confidence
  • HLEND received $1.1 billion of gross subscriptions in Q4 2025; redemptions were 4.1%, higher than recent quarters but in line with the broader industry.

    80% confidence
  • iShares set a record with $527 billion in net inflows in 2025, representing 12% organic asset growth and 13% organic base fee growth.

    80% confidence
  • Preqin added approximately $65 million of revenue in Q4 2025 and $213 million for the full year; ACV increased 31% year over year including Preqin and 16% organically.

    80% confidence
  • BlackRock expects money market yields to fall and sees opportunities for investors to lock in bond yields in intermediate-term bonds.

    80% confidence
  • Cash levels may remain elevated as global capital markets grow, and tokenization could contribute to continued cash usage including through tokenized money market funds.

    80% confidence
  • Excluding performance fees and related compensation, the Q4 2025 adjusted operating margin would have been 45.5% (up 30 bps YoY) and full-year margin 44.9% (up 60 bps vs. 2024).

    80% confidence
  • BlackRock expects to launch its first LifePath target-date fund with private markets later in 2026; plan sponsors will need standardized benchmarking and performance data which Preqin can support.

    80% confidence
  • BlackRock is working on investable private market indices it hopes to bring to market in the next few years.

    80% confidence
  • BlackRock's 2025 results validate the power of its integrated platform and the firm enters 2026 with differentiated momentum.

    80% confidence
  • BlackRock manages $700 billion in AUM as the largest general account manager for insurers across more than 450 relationships.

    80% confidence
  • BlackRock entered 2026 with accelerating momentum, a record quarterly and annual net inflows including $342 billion in Q4 2025, and a broadened pipeline across public and private markets, technology and data, and client channels.

    80% confidence
  • After annualizing the impact of HPS and Preqin, management expects a mid-single-digit percentage increase in G&A and headcount to be broadly flat in 2026.

    80% confidence
  • BlackRock contributed a portion of its Circle stake to an existing donor-advised fund in mid-December 2025 and still holds roughly 1.1 million shares of Circle common stock.

    80% confidence
  • Default rates in private credit are rising but remain within historical ranges; HPS has focused on lending to larger companies with weighted average EBITDA in the HLEND portfolio of approximately $250 million.

    80% confidence
  • Japan is experiencing faster capital markets growth driven by NISA accounts; Jio BlackRock in India is positioned to benefit from early-stage capital markets growth.

    80% confidence
  • HPS manages more than $60 billion of credit assets for more than 125 insurance companies.

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com